Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

1.7K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
1.7K
Pneumonia IV: Management01:28

Pneumonia IV: Management

267
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
267
Asthma-IV: Nursing Management01:30

Asthma-IV: Nursing Management

2.9K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
2.9K
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

109
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
109
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
2.5K
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

1.2K
Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Evolving Epidemiology of Invasive Pneumococcal Disease in Australian Children: A Multicentre Retrospective Observational Study.

Open forum infectious diseases·2026
Same author

Pertussis in Practice: Lessons From Household Transmission, Diagnostic Limitations and Genomic Surveillance.

Journal of paediatrics and child health·2026
Same author

A 19-Year Audit of Genital Mycoplasma Species in Blood Cultures From Women Attending a Tertiary Maternity Hospital.

The Australian & New Zealand journal of obstetrics & gynaecology·2026
Same author

Invasive pneumococcal disease in children with acute lymphoblastic leukaemia.

Archives of disease in childhood·2026
Same author

Community RSV Surveillance in the Long-Acting Monoclonal Antibody Era.

Journal of paediatrics and child health·2026
Same author

Determinants of respiratory syncytial virus and human metapneumovirus transmission.

Clinical microbiology reviews·2025

Related Experiment Video

Updated: May 12, 2025

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay
09:14

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay

Published on: January 26, 2019

10.7K

RSV: an update on prevention and management.

David A Foley1,2,3,4,5, Linny K Phuong1,2,3,4,5

  • 1Department of Microbiology, PathWest Laboratory Medicine WA, Perth.

Australian Prescriber
|May 9, 2025
PubMed
Summary

Respiratory syncytial virus (RSV) causes common respiratory infections. New vaccines and monoclonal antibodies offer protection against severe RSV disease in infants and older adults.

Keywords:
RSV vaccinesnirsevimabrespiratory syncytial virusrespiratory tract infections

More Related Videos

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses
11:48

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses

Published on: April 4, 2019

14.8K
An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
09:01

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

Published on: December 10, 2013

7.9K

Related Experiment Videos

Last Updated: May 12, 2025

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay
09:14

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay

Published on: January 26, 2019

10.7K
Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses
11:48

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses

Published on: April 4, 2019

14.8K
An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
09:01

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

Published on: December 10, 2013

7.9K

Area of Science:

  • Virology
  • Immunology
  • Public Health

Background:

  • Respiratory syncytial virus (RSV) is a frequent cause of respiratory infections in infants, young children, and adults over 60.
  • High-risk groups include premature infants, older adults (over 75), those with chronic conditions (cardiac, respiratory, obesity), and Aboriginal and Torres Strait Islander peoples.
  • Current RSV disease management is primarily supportive, with routine testing not recommended unless for high-risk or severely ill individuals, prioritizing influenza and COVID-19 testing due to available antivirals.

Purpose of the Study:

  • To review the current landscape of respiratory syncytial virus (RSV) infections.
  • To highlight advancements in prevention and treatment strategies for RSV.
  • To inform clinical practice regarding RSV testing and management, especially in high-risk populations.

Main Methods:

  • Literature review of recent advancements in RSV prevention and treatment.
  • Analysis of current guidelines for RSV testing and management.
  • Summary of available prophylactic measures including vaccines and monoclonal antibodies.

Main Results:

  • Recent approvals include RSV vaccines and a long-acting monoclonal antibody, offering new ways to reduce severe RSV outcomes.
  • Infant protection is achievable via maternal vaccination (28-36 weeks gestation) or post-delivery monoclonal antibody administration.
  • Two RSV vaccines are approved for older adults; no RSV vaccines are currently approved for neonates or infants.

Conclusions:

  • New prophylactic options, including maternal vaccination and monoclonal antibodies, significantly enhance protection against severe RSV in infants.
  • Approved RSV vaccines provide a crucial preventive strategy for older adults.
  • Ongoing research and development are vital for comprehensive RSV prevention and control across all age groups.